Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
XBB.1.5.3NWon-NGTTGCGACTACGTGATGAGG20552884928830R-19760.5South Korea
GG.1NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
GG.1NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
FL.3.2NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
FL.3.2NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
CK.1.5NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
CK.1.5NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
XBB.1.5.34NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
XBB.1.5.34NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
GD.1NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
GD.1NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
XBB.1.5.52NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
XBB.1.5.52NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
CH.1.1.27NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
CH.1.1.27NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
XBB.1.5.65NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
XBB.1.5.65NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
XBB.1.5.75NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
XBB.1.5.75NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
XBB.1.5.21NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
XBB.1.5.21NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
XBB.1.18.1NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
XBB.1.18.1NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
HP.1NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
HP.1NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
FU.4NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
FU.4NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
EG.1.4NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
EG.1.4NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
XBB.2.3.4NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
XBB.2.3.4NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
EY.1NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
EY.1NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
XBB.1.37.1NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
XBB.1.37.1NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
XBB.1.5.77NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
XBB.1.5.77NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
FD.4.1NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
FD.4.1NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
XBB.1.5.51NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
XBB.1.5.51NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
XBB.1.16.8NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
XBB.1.16.8NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
XBB.1.16.20NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
XBB.1.16.20NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
XBB.1.34.1NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
XBB.1.34.1NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
XBB.4NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
XBB.4NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
JD.2NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used